Market Tracker

07/29 5:16pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

2.05
Delayed Data
As of Jul 29
 -0.02 / -0.97%
Today’s Change
1.01
Today|||52-Week Range
5.15
-15.29%
Year-to-Date
Alimera (ALIM) Is Today's Strong On High Volume Stock
Jul 28 / TheStreet.com - Paid Partner Content
Mid-Afternoon Market Update: Crude Oil Drops Below $43; Linear Technology Shares Spik...
Jul 26 / Benzinga - Paid Partner Content
Alimera Sciences (ALIM) Shares March Higher, Can It Continue?
Jul 27 / Zacks.com - Paid Partner Content
Alimera Sciences (ALIM) Is in Oversold Territory: What's Next?
Jul 22 / Zacks.com - Paid Partner Content
Weak On High Volume: Alimera (ALIM)
Jul 27 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.07
Today’s open2.00
Day’s range1.85 - 2.12
Volume3,187,948
Average volume (3 months)610,300
Market cap$92.4M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+32.65%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...+0.08+1.75%
GALEGalena Biopharma Inc-0.03-5.40%
REPHRecro Pharma Inc0.000.00%
SBBPStrongbridge Biophar...-0.00-0.00%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts